Article Type
Changed
Thu, 10/19/2017 - 10:10
Display Headline
In reply: MAO inhibitors

In Reply: Dr. Keller is correct, and we thank him for the clarification. We meant to say that selegiline is the only selective MAO-B inhibitor indicated for treating depression in the United States.

Article PDF
Author and Disclosure Information

Olga Kostenko, MD
Cleveland Clinic, Cleveland, OH

Molly Wimbiscus, MD
Cleveland Clinic, Cleveland, OH

Donald Malone, MD
Cleveland Clinic, Cleveland, OH

Issue
Cleveland Clinic Journal of Medicine - 78(2)
Publications
Topics
Page Number
81
Sections
Author and Disclosure Information

Olga Kostenko, MD
Cleveland Clinic, Cleveland, OH

Molly Wimbiscus, MD
Cleveland Clinic, Cleveland, OH

Donald Malone, MD
Cleveland Clinic, Cleveland, OH

Author and Disclosure Information

Olga Kostenko, MD
Cleveland Clinic, Cleveland, OH

Molly Wimbiscus, MD
Cleveland Clinic, Cleveland, OH

Donald Malone, MD
Cleveland Clinic, Cleveland, OH

Article PDF
Article PDF
Related Articles

In Reply: Dr. Keller is correct, and we thank him for the clarification. We meant to say that selegiline is the only selective MAO-B inhibitor indicated for treating depression in the United States.

In Reply: Dr. Keller is correct, and we thank him for the clarification. We meant to say that selegiline is the only selective MAO-B inhibitor indicated for treating depression in the United States.

Issue
Cleveland Clinic Journal of Medicine - 78(2)
Issue
Cleveland Clinic Journal of Medicine - 78(2)
Page Number
81
Page Number
81
Publications
Publications
Topics
Article Type
Display Headline
In reply: MAO inhibitors
Display Headline
In reply: MAO inhibitors
Sections
Disallow All Ads
Alternative CME
Article PDF Media